ARISTIDIS HATZIDIMITRIADIS: Open Payments
NPI 1508027855 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 28 payments from 11 companies in 2025. Trend: 2023 $484 · 2024 $605 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $168 |
| ABBVIE INC. | 10 | $138 |
| Exact Sciences Corporation | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 2 | $45 |
| Novo Nordisk Inc | 2 | $36 |
| Edwards Lifesciences Corporation | 1 | $32 |
| Corcept Therapeutics | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| Abbott Laboratories | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
Products named: FARXIGA, VRAYLAR, Cologuard Collection Kit, VOQUEZNA, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), Korlym, Kerendia, QULIPTA.
Industry payments across IL — which companies pay providers there.
